Assessing Dianthus Therapeutics (DNTH) Valuation As Price To Book Sits Near 3x And Shares Show Mixed Returns [Yahoo! Finance]
Dianthus Therapeutics (NASDAQ:DNTH) had its price target raised by analysts at Truist Financial Corporation from $56.00 to $63.00. They now have a "buy" rating on the stock.
Dianthus CFO Sells 20,000 Shares for $903,600 After Massive Year-End Run [Yahoo! Finance]
Dianthus Therapeutics To Participate in the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Dianthus Therapeutics To Participate in the 44th Annual J.P. Morgan Healthcare Conference